Lactobacillus reuteri in the gut and tumor releases indole-3-aldehyde (I3A), which signals through aryl hydrocarbon receptor (AhR) on CD8+ T cells to release IFN-γ and promote antitumor immunity to anti–PD-1 therapy (54). Here, IFNG is linked to neoplasm.